Can-Fite Granted U.S. Patent for Utilization of A3 Adenosine Receptor as ...

19-12-2013 PR NewswireComments (0)

BiotechnologyCan-Fite BioPharma

Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced ...

Read more on PR Newswire

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top